Picture
SEARCH
What are you looking for?
Need help finding what you are looking for? Contact Us
Compare
Free Samples
CancerEnzyme

PUBLISHER: Global Industry Analysts, Inc. | PRODUCT CODE: 1795259

Cover Image

PUBLISHER: Global Industry Analysts, Inc. | PRODUCT CODE: 1795259

Ligases Enzyme

PUBLISHED:
PAGES: 183 Pages
DELIVERY TIME: 1-2 business days
REQUEST FREE SAMPLE
REQUEST CUSTOMIZATION
SELECT AN OPTION
PDF & Excel (Single User License)
USD 5850
PDF & Excel (Global License to Company and its Fully-owned Subsidiaries)
USD 17550

Add to Cart

Description

Table of Contents

Global Ligases Enzyme Market to Reach US$12.7 Billion by 2030

The global market for Ligases Enzyme estimated at US$7.9 Billion in the year 2024, is expected to reach US$12.7 Billion by 2030, growing at a CAGR of 8.2% over the analysis period 2024-2030. Microorganism Source, one of the segments analyzed in the report, is expected to record a 6.8% CAGR and reach US$6.2 Billion by the end of the analysis period. Growth in the Animal Source segment is estimated at 9.8% CAGR over the analysis period.

The U.S. Market is Estimated at US$2.2 Billion While China is Forecast to Grow at 12.5% CAGR

The Ligases Enzyme market in the U.S. is estimated at US$2.2 Billion in the year 2024. China, the world's second largest economy, is forecast to reach a projected market size of US$2.7 Billion by the year 2030 trailing a CAGR of 12.5% over the analysis period 2024-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 4.2% and 7.8% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 5.4% CAGR.

Global Ligases Enzyme Market - Key Trends & Drivers Summarized

How Are Ligases Enzymes Becoming Pivotal in Advancing Molecular Diagnostics and Genetic Engineering?

Ligases enzymes, critical players in molecular biology, have taken center stage in a multitude of scientific and industrial applications, especially within the realm of genetic engineering and diagnostics. These enzymes catalyze the joining of two large molecules by forming a new chemical bond, often between DNA or RNA strands, making them indispensable in the manipulation and assembly of genetic material. Their growing use in recombinant DNA technologies, cloning, and genome sequencing highlights their foundational role in modern biotechnology. In molecular diagnostics, ligases enzymes are essential for ligation-based assays, including Ligase Chain Reaction (LCR), which is a powerful method for detecting point mutations and pathogens with high sensitivity. As the prevalence of genetic disorders, infectious diseases, and cancer continues to rise globally, the demand for accurate and efficient diagnostic tools-many of which rely on ligase activity-has surged. This trend is reinforced by the need for early detection, personalized medicine, and precision diagnostics, all of which require robust and precise molecular tools. Furthermore, ligases are increasingly integrated into point-of-care diagnostic kits, offering real-time, decentralized testing solutions. This shift is especially impactful in resource-limited settings, where fast and reliable results can significantly improve patient outcomes.

What Role Do Research Institutions and Biopharmaceutical Companies Play in Propelling Ligases Innovation?

The biotechnology and pharmaceutical sectors are leading the charge in innovating ligases-based technologies, backed by vigorous research and development (R&D) initiatives. Academic institutions, often in collaboration with commercial enterprises, are at the forefront of discovering novel ligases and engineering existing ones to improve their performance across various substrates and environmental conditions. The continued refinement of thermostable ligases, capable of functioning under extreme conditions, has expanded their applicability beyond traditional laboratory environments. Major biopharma companies are increasingly adopting ligase enzymes in their drug discovery and gene therapy pipelines, notably in CRISPR-mediated gene editing, where ligases help repair double-strand DNA breaks with high specificity. These applications demand ultra-high fidelity and minimal off-target effects, reinforcing the necessity for customized ligases. Additionally, increased investment in synthetic biology-particularly in areas like synthetic genomes, metabolic pathway construction, and cell-free systems-has further solidified the market for ligases enzymes. These enzymes are also being studied for their potential in the development of next-generation vaccines, especially those based on DNA/RNA platforms. The ecosystem of innovation surrounding ligases is underpinned by public and private funding, patent activity, and the strategic interest of companies in securing intellectual property rights for novel ligation techniques.

How Is Industrial Biotechnology Fueling the Demand for Ligases in Non-Medical Sectors?

Beyond medical and academic research, ligases enzymes are carving out a significant footprint in industrial biotechnology, notably in agricultural, environmental, and food sectors. In agriculture, ligases are employed in the development of genetically modified organisms (GMOs) designed to resist pests, tolerate herbicides, or exhibit enhanced nutritional profiles. The precision and efficiency of ligases in gene assembly make them ideal tools for creating stable transgenic lines. Environmental biotechnology is another emerging arena, where ligases play a role in engineering microbes for bio-remediation and sustainable waste processing. The enzyme’s role in metagenomic analysis allows researchers to better understand microbial communities and their functions, aiding in the design of synthetic organisms tailored to degrade pollutants or recycle resources. Meanwhile, in the food industry, ligases contribute to the development of genetically improved strains used in fermentation, enzyme production, and the synthesis of food additives. As clean-label, biotech-based solutions gain favor with consumers, the utilization of ligases in non-GMO enzyme manufacturing and protein engineering grows accordingly. These industrial uses benefit from ligases’ ability to form durable, high-fidelity molecular bonds, enabling stable and scalable bioprocesses. Consequently, companies in these sectors are ramping up their adoption of ligase-based systems to increase productivity and reduce environmental impact.

What Is Powering the Momentum Behind the Expanding Ligases Enzyme Market?

The growth in the ligases enzyme market is driven by several factors deeply rooted in the evolving needs of biotechnology, healthcare, and industrial sectors. Technological advancements in genomic sequencing and synthetic biology have escalated the demand for highly efficient and specialized ligases that can operate in complex and high-throughput environments. The surge in personalized medicine, especially in oncology and rare genetic disorders, has increased the dependency on ligation-based diagnostic tools that deliver precise and individualized genetic insights. The expanding use of CRISPR-Cas systems for gene editing, where ligases facilitate accurate DNA repairs, has significantly contributed to market expansion. On the consumer side, the heightened awareness of genetic health and growing availability of at-home DNA testing kits is accelerating demand for the enzymatic tools embedded in these platforms. Additionally, increased funding for biotechnology startups, supported by favorable government policies and global interest in bio-based economies, is spurring innovation and commercial adoption of ligase-centric technologies. In industrial applications, the drive for sustainable and environmentally responsible processes has led to broader usage of ligases in biomanufacturing and agricultural engineering. Finally, the strategic focus of major enzyme producers on portfolio diversification and regional market penetration, particularly in Asia-Pacific and Latin America, is further fueling the growth trajectory of the ligases enzyme market.

SCOPE OF STUDY:

The report analyzes the Ligases Enzyme market in terms of units by the following Segments, and Geographic Regions/Countries:

Segments:

Source (Microorganism Source, Animal Source, Plant Source)

Geographic Regions/Countries:

World; United States; Canada; Japan; China; Europe (France; Germany; Italy; United Kingdom; Spain; Russia; and Rest of Europe); Asia-Pacific (Australia; India; South Korea; and Rest of Asia-Pacific); Latin America (Argentina; Brazil; Mexico; and Rest of Latin America); Middle East (Iran; Israel; Saudi Arabia; United Arab Emirates; and Rest of Middle East); and Africa.

Select Competitors (Total 42 Featured) -

  • Agilent Technologies
  • ArcticZymes Technologies ASA
  • Becton, Dickinson and Company (BD)
  • BioVision Inc.
  • Creative Enzymes
  • Cytiva (Danaher Corporation)
  • Enzo Life Sciences
  • F. Hoffmann-La Roche AG
  • GenScript
  • Illumina Inc.
  • LGC Biosearch Technologies
  • Merck KGaA
  • New England Biolabs
  • Oxford Nanopore Technologies
  • Promega Corporation
  • QIAGEN N.V.
  • R&D Systems, Inc.
  • Takara Bio Inc.
  • Thermo Fisher Scientific Inc.
  • Zymo Research
  • BASF SE

AI INTEGRATIONS

We're transforming market and competitive intelligence with validated expert content and AI tools.

Instead of following the general norm of querying LLMs and Industry-specific SLMs, we built repositories of content curated from domain experts worldwide including video transcripts, blogs, search engines research, and massive amounts of enterprise, product/service, and market data.

TARIFF IMPACT FACTOR

Our new release incorporates impact of tariffs on geographical markets as we predict a shift in competitiveness of companies based on HQ country, manufacturing base, exports and imports (finished goods and OEM). This intricate and multifaceted market reality will impact competitors by increasing the Cost of Goods Sold (COGS), reducing profitability, reconfiguring supply chains, amongst other micro and macro market dynamics.

Show more
Product Code: MCP37280

TABLE OF CONTENTS

I. METHODOLOGY

II. EXECUTIVE SUMMARY

  • 1. MARKET OVERVIEW
    • Influencer Market Insights
    • World Market Trajectories
    • Tariff Impact on Global Supply Chain Patterns
    • Ligases Enzyme - Global Key Competitors Percentage Market Share in 2025 (E)
    • Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2025 (E)
  • 2. FOCUS ON SELECT PLAYERS
  • 3. MARKET TRENDS & DRIVERS
    • Growth in Genomics and DNA Repair Research Throws the Spotlight on Ligases as Essential Molecular Tools
    • Surge in NGS and PCR-Based Applications Propels Demand for High-Fidelity DNA Ligases
    • Advancements in Molecular Cloning and Synthetic Biology Strengthen Business Case for Specialized Ligase Enzymes
    • Rising Focus on Precision Medicine and Biomarker Discovery Fuels Use of Ligases in Diagnostic Assays
    • Expansion of CRISPR and Gene Editing Platforms Generates Demand for Ligase-Compatible Enzyme Kits
    • Product Innovation in Thermostable and ATP-Independent Ligases Enhances Workflow Efficiency
    • Development of Point-of-Care and Isothermal Amplification Methods Drives Need for Rapid Ligation Enzymes
    • Increased Investment in Life Sciences R&D Globally Supports Ligase Enzyme Market Growth
    • Demand for Ligase Enzymes in DNA Library Preparation Throws the Spotlight on High-Throughput Sequencing Workflows
    • Rising Awareness of DNA Damage Repair Mechanisms Spurs Use of Ligases in Cancer Research and Drug Development
    • Growth of Biopharmaceutical Manufacturing Expands Application of Ligases in Quality Control and QC Assays
    • Evolving Enzyme Formulation and Stabilization Techniques Enable Longer Shelf Life and Broader Storage Flexibility
  • 4. GLOBAL MARKET PERSPECTIVE
    • TABLE 1: World Ligases Enzyme Market Analysis of Annual Sales in US$ Million for Years 2014 through 2030
    • TABLE 2: World Recent Past, Current & Future Analysis for Ligases Enzyme by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 3: World Historic Review for Ligases Enzyme by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 4: World 16-Year Perspective for Ligases Enzyme by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets for Years 2014, 2025 & 2030
    • TABLE 5: World Recent Past, Current & Future Analysis for Microorganism Source by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 6: World Historic Review for Microorganism Source by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 7: World 16-Year Perspective for Microorganism Source by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030
    • TABLE 8: World Recent Past, Current & Future Analysis for Animal Source by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 9: World Historic Review for Animal Source by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 10: World 16-Year Perspective for Animal Source by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030
    • TABLE 11: World Recent Past, Current & Future Analysis for Plant Source by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 12: World Historic Review for Plant Source by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 13: World 16-Year Perspective for Plant Source by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030

III. MARKET ANALYSIS

  • UNITED STATES
    • Ligases Enzyme Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2025 (E)
    • TABLE 14: USA Recent Past, Current & Future Analysis for Ligases Enzyme by Source - Microorganism Source, Animal Source and Plant Source - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 15: USA Historic Review for Ligases Enzyme by Source - Microorganism Source, Animal Source and Plant Source Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 16: USA 16-Year Perspective for Ligases Enzyme by Source - Percentage Breakdown of Value Sales for Microorganism Source, Animal Source and Plant Source for the Years 2014, 2025 & 2030
  • CANADA
    • TABLE 17: Canada Recent Past, Current & Future Analysis for Ligases Enzyme by Source - Microorganism Source, Animal Source and Plant Source - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 18: Canada Historic Review for Ligases Enzyme by Source - Microorganism Source, Animal Source and Plant Source Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 19: Canada 16-Year Perspective for Ligases Enzyme by Source - Percentage Breakdown of Value Sales for Microorganism Source, Animal Source and Plant Source for the Years 2014, 2025 & 2030
  • JAPAN
    • Ligases Enzyme Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2025 (E)
    • TABLE 20: Japan Recent Past, Current & Future Analysis for Ligases Enzyme by Source - Microorganism Source, Animal Source and Plant Source - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 21: Japan Historic Review for Ligases Enzyme by Source - Microorganism Source, Animal Source and Plant Source Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 22: Japan 16-Year Perspective for Ligases Enzyme by Source - Percentage Breakdown of Value Sales for Microorganism Source, Animal Source and Plant Source for the Years 2014, 2025 & 2030
  • CHINA
    • Ligases Enzyme Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2025 (E)
    • TABLE 23: China Recent Past, Current & Future Analysis for Ligases Enzyme by Source - Microorganism Source, Animal Source and Plant Source - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 24: China Historic Review for Ligases Enzyme by Source - Microorganism Source, Animal Source and Plant Source Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 25: China 16-Year Perspective for Ligases Enzyme by Source - Percentage Breakdown of Value Sales for Microorganism Source, Animal Source and Plant Source for the Years 2014, 2025 & 2030
  • EUROPE
    • Ligases Enzyme Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2025 (E)
    • TABLE 26: Europe Recent Past, Current & Future Analysis for Ligases Enzyme by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 27: Europe Historic Review for Ligases Enzyme by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 28: Europe 16-Year Perspective for Ligases Enzyme by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets for Years 2014, 2025 & 2030
    • TABLE 29: Europe Recent Past, Current & Future Analysis for Ligases Enzyme by Source - Microorganism Source, Animal Source and Plant Source - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 30: Europe Historic Review for Ligases Enzyme by Source - Microorganism Source, Animal Source and Plant Source Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 31: Europe 16-Year Perspective for Ligases Enzyme by Source - Percentage Breakdown of Value Sales for Microorganism Source, Animal Source and Plant Source for the Years 2014, 2025 & 2030
  • FRANCE
    • Ligases Enzyme Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2025 (E)
    • TABLE 32: France Recent Past, Current & Future Analysis for Ligases Enzyme by Source - Microorganism Source, Animal Source and Plant Source - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 33: France Historic Review for Ligases Enzyme by Source - Microorganism Source, Animal Source and Plant Source Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 34: France 16-Year Perspective for Ligases Enzyme by Source - Percentage Breakdown of Value Sales for Microorganism Source, Animal Source and Plant Source for the Years 2014, 2025 & 2030
  • GERMANY
    • Ligases Enzyme Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2025 (E)
    • TABLE 35: Germany Recent Past, Current & Future Analysis for Ligases Enzyme by Source - Microorganism Source, Animal Source and Plant Source - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 36: Germany Historic Review for Ligases Enzyme by Source - Microorganism Source, Animal Source and Plant Source Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 37: Germany 16-Year Perspective for Ligases Enzyme by Source - Percentage Breakdown of Value Sales for Microorganism Source, Animal Source and Plant Source for the Years 2014, 2025 & 2030
  • ITALY
    • TABLE 38: Italy Recent Past, Current & Future Analysis for Ligases Enzyme by Source - Microorganism Source, Animal Source and Plant Source - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 39: Italy Historic Review for Ligases Enzyme by Source - Microorganism Source, Animal Source and Plant Source Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 40: Italy 16-Year Perspective for Ligases Enzyme by Source - Percentage Breakdown of Value Sales for Microorganism Source, Animal Source and Plant Source for the Years 2014, 2025 & 2030
  • UNITED KINGDOM
    • Ligases Enzyme Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2025 (E)
    • TABLE 41: UK Recent Past, Current & Future Analysis for Ligases Enzyme by Source - Microorganism Source, Animal Source and Plant Source - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 42: UK Historic Review for Ligases Enzyme by Source - Microorganism Source, Animal Source and Plant Source Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 43: UK 16-Year Perspective for Ligases Enzyme by Source - Percentage Breakdown of Value Sales for Microorganism Source, Animal Source and Plant Source for the Years 2014, 2025 & 2030
  • SPAIN
    • TABLE 44: Spain Recent Past, Current & Future Analysis for Ligases Enzyme by Source - Microorganism Source, Animal Source and Plant Source - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 45: Spain Historic Review for Ligases Enzyme by Source - Microorganism Source, Animal Source and Plant Source Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 46: Spain 16-Year Perspective for Ligases Enzyme by Source - Percentage Breakdown of Value Sales for Microorganism Source, Animal Source and Plant Source for the Years 2014, 2025 & 2030
  • RUSSIA
    • TABLE 47: Russia Recent Past, Current & Future Analysis for Ligases Enzyme by Source - Microorganism Source, Animal Source and Plant Source - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 48: Russia Historic Review for Ligases Enzyme by Source - Microorganism Source, Animal Source and Plant Source Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 49: Russia 16-Year Perspective for Ligases Enzyme by Source - Percentage Breakdown of Value Sales for Microorganism Source, Animal Source and Plant Source for the Years 2014, 2025 & 2030
  • REST OF EUROPE
    • TABLE 50: Rest of Europe Recent Past, Current & Future Analysis for Ligases Enzyme by Source - Microorganism Source, Animal Source and Plant Source - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 51: Rest of Europe Historic Review for Ligases Enzyme by Source - Microorganism Source, Animal Source and Plant Source Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 52: Rest of Europe 16-Year Perspective for Ligases Enzyme by Source - Percentage Breakdown of Value Sales for Microorganism Source, Animal Source and Plant Source for the Years 2014, 2025 & 2030
  • ASIA-PACIFIC
    • Ligases Enzyme Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2025 (E)
    • TABLE 53: Asia-Pacific Recent Past, Current & Future Analysis for Ligases Enzyme by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 54: Asia-Pacific Historic Review for Ligases Enzyme by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 55: Asia-Pacific 16-Year Perspective for Ligases Enzyme by Geographic Region - Percentage Breakdown of Value Sales for Australia, India, South Korea and Rest of Asia-Pacific Markets for Years 2014, 2025 & 2030
    • TABLE 56: Asia-Pacific Recent Past, Current & Future Analysis for Ligases Enzyme by Source - Microorganism Source, Animal Source and Plant Source - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 57: Asia-Pacific Historic Review for Ligases Enzyme by Source - Microorganism Source, Animal Source and Plant Source Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 58: Asia-Pacific 16-Year Perspective for Ligases Enzyme by Source - Percentage Breakdown of Value Sales for Microorganism Source, Animal Source and Plant Source for the Years 2014, 2025 & 2030
  • AUSTRALIA
    • Ligases Enzyme Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Australia for 2025 (E)
    • TABLE 59: Australia Recent Past, Current & Future Analysis for Ligases Enzyme by Source - Microorganism Source, Animal Source and Plant Source - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 60: Australia Historic Review for Ligases Enzyme by Source - Microorganism Source, Animal Source and Plant Source Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 61: Australia 16-Year Perspective for Ligases Enzyme by Source - Percentage Breakdown of Value Sales for Microorganism Source, Animal Source and Plant Source for the Years 2014, 2025 & 2030
  • INDIA
    • Ligases Enzyme Market Presence - Strong/Active/Niche/Trivial - Key Competitors in India for 2025 (E)
    • TABLE 62: India Recent Past, Current & Future Analysis for Ligases Enzyme by Source - Microorganism Source, Animal Source and Plant Source - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 63: India Historic Review for Ligases Enzyme by Source - Microorganism Source, Animal Source and Plant Source Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 64: India 16-Year Perspective for Ligases Enzyme by Source - Percentage Breakdown of Value Sales for Microorganism Source, Animal Source and Plant Source for the Years 2014, 2025 & 2030
  • SOUTH KOREA
    • TABLE 65: South Korea Recent Past, Current & Future Analysis for Ligases Enzyme by Source - Microorganism Source, Animal Source and Plant Source - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 66: South Korea Historic Review for Ligases Enzyme by Source - Microorganism Source, Animal Source and Plant Source Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 67: South Korea 16-Year Perspective for Ligases Enzyme by Source - Percentage Breakdown of Value Sales for Microorganism Source, Animal Source and Plant Source for the Years 2014, 2025 & 2030
  • REST OF ASIA-PACIFIC
    • TABLE 68: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Ligases Enzyme by Source - Microorganism Source, Animal Source and Plant Source - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 69: Rest of Asia-Pacific Historic Review for Ligases Enzyme by Source - Microorganism Source, Animal Source and Plant Source Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 70: Rest of Asia-Pacific 16-Year Perspective for Ligases Enzyme by Source - Percentage Breakdown of Value Sales for Microorganism Source, Animal Source and Plant Source for the Years 2014, 2025 & 2030
  • LATIN AMERICA
    • Ligases Enzyme Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Latin America for 2025 (E)
    • TABLE 71: Latin America Recent Past, Current & Future Analysis for Ligases Enzyme by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 72: Latin America Historic Review for Ligases Enzyme by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 73: Latin America 16-Year Perspective for Ligases Enzyme by Geographic Region - Percentage Breakdown of Value Sales for Argentina, Brazil, Mexico and Rest of Latin America Markets for Years 2014, 2025 & 2030
    • TABLE 74: Latin America Recent Past, Current & Future Analysis for Ligases Enzyme by Source - Microorganism Source, Animal Source and Plant Source - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 75: Latin America Historic Review for Ligases Enzyme by Source - Microorganism Source, Animal Source and Plant Source Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 76: Latin America 16-Year Perspective for Ligases Enzyme by Source - Percentage Breakdown of Value Sales for Microorganism Source, Animal Source and Plant Source for the Years 2014, 2025 & 2030
  • ARGENTINA
    • TABLE 77: Argentina Recent Past, Current & Future Analysis for Ligases Enzyme by Source - Microorganism Source, Animal Source and Plant Source - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 78: Argentina Historic Review for Ligases Enzyme by Source - Microorganism Source, Animal Source and Plant Source Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 79: Argentina 16-Year Perspective for Ligases Enzyme by Source - Percentage Breakdown of Value Sales for Microorganism Source, Animal Source and Plant Source for the Years 2014, 2025 & 2030
  • BRAZIL
    • TABLE 80: Brazil Recent Past, Current & Future Analysis for Ligases Enzyme by Source - Microorganism Source, Animal Source and Plant Source - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 81: Brazil Historic Review for Ligases Enzyme by Source - Microorganism Source, Animal Source and Plant Source Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 82: Brazil 16-Year Perspective for Ligases Enzyme by Source - Percentage Breakdown of Value Sales for Microorganism Source, Animal Source and Plant Source for the Years 2014, 2025 & 2030
  • MEXICO
    • TABLE 83: Mexico Recent Past, Current & Future Analysis for Ligases Enzyme by Source - Microorganism Source, Animal Source and Plant Source - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 84: Mexico Historic Review for Ligases Enzyme by Source - Microorganism Source, Animal Source and Plant Source Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 85: Mexico 16-Year Perspective for Ligases Enzyme by Source - Percentage Breakdown of Value Sales for Microorganism Source, Animal Source and Plant Source for the Years 2014, 2025 & 2030
  • REST OF LATIN AMERICA
    • TABLE 86: Rest of Latin America Recent Past, Current & Future Analysis for Ligases Enzyme by Source - Microorganism Source, Animal Source and Plant Source - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 87: Rest of Latin America Historic Review for Ligases Enzyme by Source - Microorganism Source, Animal Source and Plant Source Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 88: Rest of Latin America 16-Year Perspective for Ligases Enzyme by Source - Percentage Breakdown of Value Sales for Microorganism Source, Animal Source and Plant Source for the Years 2014, 2025 & 2030
  • MIDDLE EAST
    • Ligases Enzyme Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Middle East for 2025 (E)
    • TABLE 89: Middle East Recent Past, Current & Future Analysis for Ligases Enzyme by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 90: Middle East Historic Review for Ligases Enzyme by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 91: Middle East 16-Year Perspective for Ligases Enzyme by Geographic Region - Percentage Breakdown of Value Sales for Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets for Years 2014, 2025 & 2030
    • TABLE 92: Middle East Recent Past, Current & Future Analysis for Ligases Enzyme by Source - Microorganism Source, Animal Source and Plant Source - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 93: Middle East Historic Review for Ligases Enzyme by Source - Microorganism Source, Animal Source and Plant Source Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 94: Middle East 16-Year Perspective for Ligases Enzyme by Source - Percentage Breakdown of Value Sales for Microorganism Source, Animal Source and Plant Source for the Years 2014, 2025 & 2030
  • IRAN
    • TABLE 95: Iran Recent Past, Current & Future Analysis for Ligases Enzyme by Source - Microorganism Source, Animal Source and Plant Source - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 96: Iran Historic Review for Ligases Enzyme by Source - Microorganism Source, Animal Source and Plant Source Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 97: Iran 16-Year Perspective for Ligases Enzyme by Source - Percentage Breakdown of Value Sales for Microorganism Source, Animal Source and Plant Source for the Years 2014, 2025 & 2030
  • ISRAEL
    • TABLE 98: Israel Recent Past, Current & Future Analysis for Ligases Enzyme by Source - Microorganism Source, Animal Source and Plant Source - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 99: Israel Historic Review for Ligases Enzyme by Source - Microorganism Source, Animal Source and Plant Source Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 100: Israel 16-Year Perspective for Ligases Enzyme by Source - Percentage Breakdown of Value Sales for Microorganism Source, Animal Source and Plant Source for the Years 2014, 2025 & 2030
  • SAUDI ARABIA
    • TABLE 101: Saudi Arabia Recent Past, Current & Future Analysis for Ligases Enzyme by Source - Microorganism Source, Animal Source and Plant Source - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 102: Saudi Arabia Historic Review for Ligases Enzyme by Source - Microorganism Source, Animal Source and Plant Source Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 103: Saudi Arabia 16-Year Perspective for Ligases Enzyme by Source - Percentage Breakdown of Value Sales for Microorganism Source, Animal Source and Plant Source for the Years 2014, 2025 & 2030
  • UNITED ARAB EMIRATES
    • TABLE 104: UAE Recent Past, Current & Future Analysis for Ligases Enzyme by Source - Microorganism Source, Animal Source and Plant Source - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 105: UAE Historic Review for Ligases Enzyme by Source - Microorganism Source, Animal Source and Plant Source Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 106: UAE 16-Year Perspective for Ligases Enzyme by Source - Percentage Breakdown of Value Sales for Microorganism Source, Animal Source and Plant Source for the Years 2014, 2025 & 2030
  • REST OF MIDDLE EAST
    • TABLE 107: Rest of Middle East Recent Past, Current & Future Analysis for Ligases Enzyme by Source - Microorganism Source, Animal Source and Plant Source - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 108: Rest of Middle East Historic Review for Ligases Enzyme by Source - Microorganism Source, Animal Source and Plant Source Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 109: Rest of Middle East 16-Year Perspective for Ligases Enzyme by Source - Percentage Breakdown of Value Sales for Microorganism Source, Animal Source and Plant Source for the Years 2014, 2025 & 2030
  • AFRICA
    • Ligases Enzyme Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Africa for 2025 (E)
    • TABLE 110: Africa Recent Past, Current & Future Analysis for Ligases Enzyme by Source - Microorganism Source, Animal Source and Plant Source - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 111: Africa Historic Review for Ligases Enzyme by Source - Microorganism Source, Animal Source and Plant Source Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 112: Africa 16-Year Perspective for Ligases Enzyme by Source - Percentage Breakdown of Value Sales for Microorganism Source, Animal Source and Plant Source for the Years 2014, 2025 & 2030

IV. COMPETITION

Show more
Have a question?
Picture

Jeroen Van Heghe

Manager - EMEA

+32-2-535-7543

Picture

Christine Sirois

Manager - Americas

+1-860-674-8796

Questions? Please give us a call or visit the contact form.
Contact Us +1-866-353-3335
Hi, how can we help?
Contact us!